LoginRegister
    Novartis hands investors Alcon spin-off, 5 billion dollar share buybackNovartis hands investors Alcon spin-off, 5 billion dollar share buyback
    AstraZeneca wins speedy approvals for cancer drugs in JapanAstraZeneca wins speedy approvals for cancer drugs in Japan
    Oxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, importOxytocin ban: CDSCO raids in Bihar on Illegal Manufacturing, import
    Dr Reddys recalls 2.36 lakh bottles of cholesterol lowering tablets from USDr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from US
    Zydus Cadila gets USFDA nod for blood pressure drugZydus Cadila gets USFDA nod for blood pressure drug
    Rival Novartis, Gilead CAR-T therapies win European panel recommendationRival Novartis, Gilead CAR-T therapies win European panel recommendation
    AbbVie, AndroGel partner owe 448 million dollar in antitrust case: US judgeAbbVie, AndroGel partner owe 448 million dollar in antitrust case: US judge
    FDA approves Dermiras wipe for excessive armpit sweatingFDA approves Dermira's wipe for excessive armpit sweating
    Soon: New Calculations to come at Ceiling Prices for Essential MedicinesSoon: New Calculations to come at Ceiling Prices for Essential Medicines
    SEBI has ordered a forensic audit of the company: FortisSEBI has ordered a forensic audit of the company: Fortis
    Private equity firms invest record 8.2 billion dollar in June quarterPrivate equity firms invest record 8.2 billion dollar in June quarter
    FDA approves novel device for treating breathing difficulty from severe emphysemaFDA approves novel device for treating breathing difficulty from severe emphysema
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X